{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T01:27:19Z","timestamp":1779240439642,"version":"3.51.4"},"reference-count":90,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2012,10,10]],"date-time":"2012-10-10T00:00:00Z","timestamp":1349827200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinic Rev Allerg Immunol"],"published-print":{"date-parts":[[2013,2]]},"DOI":"10.1007\/s12016-012-8335-x","type":"journal-article","created":{"date-parts":[[2012,10,9]],"date-time":"2012-10-09T17:34:12Z","timestamp":1349804052000},"page":"1-5","source":"Crossref","is-referenced-by-count":19,"title":["The Autoimmune Side of Heart and Lung Diseases"],"prefix":"10.1007","volume":"44","author":[{"given":"Nancy","family":"Agmon-Levin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlo","family":"Selmi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,10,10]]},"reference":[{"key":"8335_CR1","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.autrev.2010.09.012","volume":"10","author":"G Bussone","year":"2011","unstructured":"Bussone G, Mouthon L (2011) Interstitial lung disease in systemic sclerosis. Autoimmun Rev 10:248\u2013255","journal-title":"Autoimmun Rev"},{"key":"8335_CR2","doi-asserted-by":"crossref","first-page":"2635","DOI":"10.4049\/jimmunol.1201115","volume":"189","author":"CG Lee","year":"2012","unstructured":"Lee CG, Herzog EL, Ahangari F et al (2012) Chitinase 1 is a biomarker for and therapeutic target in scleroderma-associated interstitial lung disease that augments TGF-beta1 signaling. J Immunol 189:2635\u20132644","journal-title":"J Immunol"},{"key":"8335_CR3","doi-asserted-by":"crossref","first-page":"5693","DOI":"10.4049\/jimmunol.163.10.5693","volume":"163","author":"LL McCormick","year":"1999","unstructured":"McCormick LL, Zhang Y, Tootell E, Gilliam AC (1999) Anti-TGF-beta treatment prevents skin and lung fibrosis in murine sclerodermatous graft-versus-host disease: a model for human scleroderma. J Immunol 163:5693\u20135699","journal-title":"J Immunol"},{"key":"8335_CR4","doi-asserted-by":"crossref","unstructured":"Szczeklik W, Jakiela B, Adamek D and Musial J (2011) Cutting edge issues in the Churg\u2013Strauss syndrome. Clin Rev Allergy Immunol. doi: 10.1007\/s12016-011-8266-y","DOI":"10.1007\/s12016-011-8266-y"},{"key":"8335_CR5","doi-asserted-by":"crossref","unstructured":"Bartoloni E, Alunno A, Bistoni O and Gerli R (2011) Cardiovascular risk in rheumatoid arthritis and systemic autoimmune rheumatic disorders: a suggested model of preventive strategy. Clin Rev Allergy Immunol. doi: 10.1007\/s12016-010-8251-x","DOI":"10.1007\/s12016-010-8251-x"},{"key":"8335_CR6","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.jaut.2011.01.006","volume":"36","author":"G Fousteri","year":"2011","unstructured":"Fousteri G, Dave A, Morin B, Omid S, Croft M, von Herrath MG (2011) Nasal cardiac myosin peptide treatment and OX40 blockade protect mice from acute and chronic virally-induced myocarditis. J Autoimmun 36:210\u2013220","journal-title":"J Autoimmun"},{"key":"8335_CR7","doi-asserted-by":"crossref","first-page":"5662","DOI":"10.4049\/jimmunol.176.9.5662","volume":"176","author":"KC Fae","year":"2006","unstructured":"Fae KC, da Silva DD, Oshiro SE et al (2006) Mimicry in recognition of cardiac myosin peptides by heart-intralesional T cell clones from rheumatic heart disease. J Immunol 176:5662\u20135670","journal-title":"J Immunol"},{"key":"8335_CR8","doi-asserted-by":"crossref","first-page":"6836","DOI":"10.4049\/jimmunol.162.11.6836","volume":"162","author":"EV Fedoseyeva","year":"1999","unstructured":"Fedoseyeva EV, Zhang F, Orr PL, Levin D, Buncke HJ, Benichou G (1999) De novo autoimmunity to cardiac myosin after heart transplantation and its contribution to the rejection process. J Immunol 162:6836\u20136842","journal-title":"J Immunol"},{"key":"8335_CR9","doi-asserted-by":"crossref","unstructured":"Nussinovitch U and Shoenfeld Y (2011) The clinical and diagnostic significance of anti-myosin autoantibodies in cardiac disease. Clin Rev Allergy Immunol. doi: 10.1007\/s12016-010-8229-8","DOI":"10.1007\/s12016-010-8229-8"},{"key":"8335_CR10","doi-asserted-by":"crossref","unstructured":"Nussinovitch U and Shoenfeld Y (2010) The Clinical significance of anti-beta-1 adrenergic receptor autoantibodies in cardiac disease. Clin Rev Allergy Immunol. doi: 10.1007\/s12016-010-8228-9","DOI":"10.1007\/s12016-010-8228-9"},{"key":"8335_CR11","doi-asserted-by":"crossref","unstructured":"Roux-Lombard P, Pagano S, Montecucco F, Satta N and Vuilleumier N (2010) Auto-antibodies as emergent prognostic markers and possible mediators of ischemic cardiovascular diseases. Clin Rev Allergy Immunol. doi: 10.1007\/s12016-010-8233-z","DOI":"10.1007\/s12016-010-8233-z"},{"key":"8335_CR12","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.4049\/jimmunol.1004195","volume":"187","author":"S Kalache","year":"2011","unstructured":"Kalache S, Dinavahi R, Pinney S, Mehrotra A, Cunningham MW, Heeger PS (2011) Anticardiac myosin immunity and chronic allograft vasculopathy in heart transplant recipients. J Immunol 187:1023\u20131030","journal-title":"J Immunol"},{"key":"8335_CR13","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.jaut.2011.05.004","volume":"37","author":"SM Fu","year":"2011","unstructured":"Fu SM, Deshmukh US, Gaskin F (2011) Pathogenesis of systemic lupus erythematosus revisited 2011: end organ resistance to damage, autoantibody initiation and diversification, and HLA-DR. J Autoimmun 37:104\u2013112","journal-title":"J Autoimmun"},{"key":"8335_CR14","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.jaut.2010.10.007","volume":"36","author":"CL Hickman-Brecks","year":"2011","unstructured":"Hickman-Brecks CL, Racz JL, Meyer DM, LaBranche TP, Allen PM (2011) Th17 cells can provide B cell help in autoantibody induced arthritis. J Autoimmun 36:65\u201375","journal-title":"J Autoimmun"},{"key":"8335_CR15","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.jaut.2009.06.005","volume":"34","author":"E Karnabi","year":"2010","unstructured":"Karnabi E, Qu Y, Wadgaonkar R et al (2010) Congenital heart block: identification of autoantibody binding site on the extracellular loop (domain I, S5-S6) of alpha(1D) L-type Ca channel. J Autoimmun 34:80\u201386","journal-title":"J Autoimmun"},{"key":"8335_CR16","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.jaut.2010.07.007","volume":"35","author":"TP Lee","year":"2010","unstructured":"Lee TP, Tang SJ, Wu MF, Song YC, Yu CL, Sun KH (2010) Transgenic overexpression of anti-double-stranded DNA autoantibody and activation of Toll-like receptor 4 in mice induce severe systemic lupus erythematosus syndromes. J Autoimmun 35:358\u2013367","journal-title":"J Autoimmun"},{"key":"8335_CR17","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.jaut.2010.10.003","volume":"36","author":"K Somers","year":"2011","unstructured":"Somers K, Geusens P, Elewaut D et al (2011) Novel autoantibody markers for early and seronegative rheumatoid arthritis. J Autoimmun 36:33\u201346","journal-title":"J Autoimmun"},{"key":"8335_CR18","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.autrev.2010.08.014","volume":"10","author":"A Doria","year":"2010","unstructured":"Doria A, Zen M, Canova M et al (2010) SLE diagnosis and treatment: when early is early. Autoimmun Rev 10:55\u201360","journal-title":"Autoimmun Rev"},{"key":"8335_CR19","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.autrev.2010.09.001","volume":"10","author":"G Hernandez-Molina","year":"2011","unstructured":"Hernandez-Molina G, Leal-Alegre G, Michel-Peregrina M (2011) The meaning of anti-Ro and anti-La antibodies in primary Sjogren\u2019s syndrome. Autoimmun Rev 10:123\u2013125","journal-title":"Autoimmun Rev"},{"key":"8335_CR20","doi-asserted-by":"crossref","first-page":"A259","DOI":"10.1016\/j.autrev.2009.12.002","volume":"9","author":"A Lleo","year":"2010","unstructured":"Lleo A, Invernizzi P, Gao B, Podda M, Gershwin ME (2010) Definition of human autoimmunity\u2013autoantibodies versus autoimmune disease. Autoimmun Rev 9:A259\u2013A266","journal-title":"Autoimmun Rev"},{"key":"8335_CR21","doi-asserted-by":"crossref","unstructured":"Cantarini L, Imazio M, Brizi MG et al (2010) Role of autoimmunity and autoinflammation in the pathogenesis of idiopathic recurrent pericarditis. Clin Rev Allergy Immunol. doi: 10.1007\/s12016-010-8219-x","DOI":"10.1007\/s12016-010-8219-x"},{"key":"8335_CR22","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.jaut.2010.06.009","volume":"35","author":"E Kontaki","year":"2010","unstructured":"Kontaki E, Boumpas DT (2010) Innate immunity in systemic lupus erythematosus: sensing endogenous nucleic acids. J Autoimmun 35:206\u2013211","journal-title":"J Autoimmun"},{"key":"8335_CR23","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.autrev.2009.11.021","volume":"9","author":"L Cantarini","year":"2010","unstructured":"Cantarini L, Imazio M, Brucato A, Lucherini OM, Galeazzi M (2010) Innate versus acquired immune response in the pathogenesis of recurrent idiopathic pericarditis. Autoimmun Rev 9:436\u2013440","journal-title":"Autoimmun Rev"},{"key":"8335_CR24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12016-009-8137-y","volume":"38","author":"A Etzioni","year":"2010","unstructured":"Etzioni A (2010) Contemporary challenges in human innate immunodeficiency syndromes. Clin rev allergy & immunolo 38:1\u20132","journal-title":"Clin rev allergy & immunolo"},{"key":"8335_CR25","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1007\/s12016-010-8227-x","volume":"41","author":"A Wollenberg","year":"2011","unstructured":"Wollenberg A, Rawer HC, Schauber J (2011) Innate immunity in atopic dermatitis. Clin rev allergy immunol 41:272\u2013281","journal-title":"Clin rev allergy immunol"},{"key":"8335_CR26","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1016\/j.autrev.2010.05.006","volume":"9","author":"MM Varin","year":"2010","unstructured":"Varin MM, Le Pottier L, Youinou P, Saulep D, Mackay F, Pers JO (2010) B-cell tolerance breakdown in Sjogren\u2019s syndrome: focus on BAFF. Autoimmun Rev 9:604\u2013608","journal-title":"Autoimmun Rev"},{"key":"8335_CR27","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/j.autrev.2010.07.006","volume":"9","author":"M Benucci","year":"2010","unstructured":"Benucci M, Manfredi M, Puttini PS, Atzeni F (2010) Predictive factors of response to rituximab therapy in rheumatoid arthritis: what do we know today? Autoimmun Rev 9:801\u2013803","journal-title":"Autoimmun Rev"},{"key":"8335_CR28","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1016\/j.autrev.2010.07.013","volume":"9","author":"F Conti","year":"2010","unstructured":"Conti F, Perricone C, Ceccarelli F, Valesini G (2010) Rituximab treatment of systemic lupus erythematosus in controlled trials and in clinical practice: two sides of the same coin. Autoimmun Rev 9:716\u2013720","journal-title":"Autoimmun Rev"},{"key":"8335_CR29","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/j.autrev.2010.05.007","volume":"9","author":"A Saraux","year":"2010","unstructured":"Saraux A (2010) The point on the ongoing B-cell depleting trials currently in progress over the world in primary Sjogren\u2019s syndrome. Autoimmun Rev 9:609\u2013614","journal-title":"Autoimmun Rev"},{"key":"8335_CR30","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.jaut.2011.05.002","volume":"37","author":"M Behrens","year":"2011","unstructured":"Behrens M, Smart M, Luckey D, Luthra H, Taneja V (2011) To B or not to B: role of B cells in pathogenesis of arthritis in HLA transgenic mice. J Autoimmun 37:95\u2013103","journal-title":"J Autoimmun"},{"key":"8335_CR31","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.jaut.2010.02.001","volume":"35","author":"RK Arora-Singh","year":"2010","unstructured":"Arora-Singh RK, Assassi S, del Junco DJ et al (2010) Autoimmune diseases and autoantibodies in the first degree relatives of patients with systemic sclerosis. J Autoimmun 35:52\u201357","journal-title":"J Autoimmun"},{"key":"8335_CR32","doi-asserted-by":"crossref","first-page":"4747","DOI":"10.4049\/jimmunol.1103055","volume":"188","author":"Y Xiang","year":"2012","unstructured":"Xiang Y, Peng J, Tai N et al (2012) The dual effects of B cell depletion on antigen-specific T cells in BDC2.5NOD mice. J Immunol 188:4747\u20134758","journal-title":"J Immunol"},{"key":"8335_CR33","doi-asserted-by":"crossref","first-page":"3351","DOI":"10.4049\/jimmunol.179.5.3351","volume":"179","author":"A Ahuja","year":"2007","unstructured":"Ahuja A, Shupe J, Dunn R, Kashgarian M, Kehry MR, Shlomchik MJ (2007) Depletion of B cells in murine lupus: efficacy and resistance. J Immunol 179:3351\u20133361","journal-title":"J Immunol"},{"key":"8335_CR34","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.autrev.2010.06.012","volume":"11","author":"M Fabris","year":"2012","unstructured":"Fabris M, Quartuccio L, Lombardi S et al (2012) The CC homozygosis of the -174\u00a0G\u2009>\u2009C IL-6 polymorphism predicts a lower efficacy of rituximab therapy in rheumatoid arthritis. Autoimmun Rev 11:315\u2013320","journal-title":"Autoimmun Rev"},{"key":"8335_CR35","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1038\/nm.2323","volume":"17","author":"L Chin","year":"2011","unstructured":"Chin L, Andersen JN, Futreal PA (2011) Cancer genomics: from discovery science to personalized medicine. Nat med 17:297\u2013303","journal-title":"Nat med"},{"key":"8335_CR36","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1038\/nm.2130","volume":"16","author":"EF McKinney","year":"2010","unstructured":"McKinney EF, Lyons PA, Carr EJ et al (2010) A CD8+ T cell transcription signature predicts prognosis in autoimmune disease. Nat med 16:586\u2013591, 581p following 591","journal-title":"Nat med"},{"key":"8335_CR37","doi-asserted-by":"crossref","first-page":"J207","DOI":"10.1016\/j.jaut.2009.12.006","volume":"34","author":"WH Brooks","year":"2010","unstructured":"Brooks WH, Le Dantec C, Pers JO, Youinou P, Renaudineau Y (2010) Epigenetics and autoimmunity. J Autoimmun 34:J207\u2013J219","journal-title":"J Autoimmun"},{"key":"8335_CR38","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1007\/s12016-009-8168-4","volume":"39","author":"E Ballestar","year":"2010","unstructured":"Ballestar E (2010) Epigenetics lessons from twins: prospects for autoimmune disease. Clin rev allergy immunol 39:30\u201341","journal-title":"Clin rev allergy immunol"},{"key":"8335_CR39","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1007\/s12016-009-8169-3","volume":"39","author":"A Grolleau-Julius","year":"2010","unstructured":"Grolleau-Julius A, Ray D, Yung RL (2010) The role of epigenetics in aging and autoimmunity. Clin rev allergy immunol 39:42\u201350","journal-title":"Clin rev allergy immunol"},{"key":"8335_CR40","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12016-009-8171-9","volume":"39","author":"Y Renaudineau","year":"2010","unstructured":"Renaudineau Y (2010) The revolution of epigenetics in the field of autoimmunity. Clin rev allergy immunol 39:1\u20132","journal-title":"Clin rev allergy immunol"},{"key":"8335_CR41","doi-asserted-by":"crossref","first-page":"3918","DOI":"10.4049\/jimmunol.1003099","volume":"186","author":"SA McClymont","year":"2011","unstructured":"McClymont SA, Putnam AL, Lee MR et al (2011) Plasticity of human regulatory T cells in healthy subjects and patients with type 1 diabetes. J Immunol 186:3918\u20133926","journal-title":"J Immunol"},{"key":"8335_CR42","doi-asserted-by":"crossref","first-page":"2609","DOI":"10.4049\/jimmunol.179.4.2609","volume":"179","author":"WW Lee","year":"2007","unstructured":"Lee WW, Yang ZZ, Li G, Weyand CM, Goronzy JJ (2007) Unchecked CD70 expression on T cells lowers threshold for T cell activation in rheumatoid arthritis. J Immunol 179:2609\u20132615","journal-title":"J Immunol"},{"key":"8335_CR43","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1007\/s12016-009-8166-6","volume":"39","author":"M Trenkmann","year":"2010","unstructured":"Trenkmann M, Brock M, Ospelt C, Gay S (2010) Epigenetics in rheumatoid arthritis. Clin rev allergy immunol 39:10\u201319","journal-title":"Clin rev allergy immunol"},{"key":"8335_CR44","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s12016-009-8165-7","volume":"39","author":"S Zhao","year":"2010","unstructured":"Zhao S, Long H, Lu Q (2010) Epigenetic perspectives in systemic lupus erythematosus: pathogenesis, biomarkers, and therapeutic potentials. Clin rev allergy immunol 39:3\u20139","journal-title":"Clin rev allergy immunol"},{"key":"8335_CR45","doi-asserted-by":"crossref","unstructured":"Selmi C, Leung PS, Sherr DH et al (2012) Mechanisms of environmental influence on human autoimmunity: A National Institute of Environmental Health Sciences Expert Panel workshop. J Autoimmun. doi: 10.1016\/j.jaut.2012.05.007","DOI":"10.1016\/j.jaut.2012.05.007"},{"key":"8335_CR46","doi-asserted-by":"crossref","unstructured":"Miller FW, Alfredsson L, Costenbader KH et al (2012) Epidemiology of environmental exposures and human autoimmune diseases: findings from a National Institute of Environmental Health Sciences Expert Panel workshop. J Autoimmun. doi: 10.1016\/j.jaut.2012.05.002","DOI":"10.1016\/j.jaut.2012.05.002"},{"key":"8335_CR47","doi-asserted-by":"crossref","unstructured":"Germolec D, Kono DH, Pfau JC and Pollard KM (2012) Animal models used to examine the role of the environment in the development of autoimmune disease: findings from an NIEHS Expert Panel Workshop. J Autoimmun. doi: 10.1016\/j.jaut.2012.05.020","DOI":"10.1016\/j.jaut.2012.05.020"},{"key":"8335_CR48","doi-asserted-by":"crossref","unstructured":"Miller FW, Pollard KM, Parks CG et al (2012) Criteria for environmentally associated autoimmune diseases. J Autoimmun. doi: 10.1016\/j.jaut.2012.05.001","DOI":"10.1016\/j.jaut.2012.05.001"},{"key":"8335_CR49","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.jaut.2011.01.001","volume":"36","author":"R Sharma","year":"2011","unstructured":"Sharma R, Fu SM, Ju ST (2011) IL-2: a two-faced master regulator of autoimmunity. J Autoimmun 36:91\u201397","journal-title":"J Autoimmun"},{"key":"8335_CR50","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.autrev.2010.08.003","volume":"10","author":"J Baraut","year":"2010","unstructured":"Baraut J, Michel L, Verrecchia F, Farge D (2010) Relationship between cytokine profiles and clinical outcomes in patients with systemic sclerosis. Autoimmun Rev 10:65\u201373","journal-title":"Autoimmun Rev"},{"key":"8335_CR51","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.jaut.2009.07.011","volume":"34","author":"YH Oo","year":"2010","unstructured":"Oo YH, Adams DH (2010) The role of chemokines in the recruitment of lymphocytes to the liver. J Autoimmun 34:45\u201354","journal-title":"J Autoimmun"},{"key":"8335_CR52","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jaut.2009.08.008","volume":"34","author":"G Tiegs","year":"2010","unstructured":"Tiegs G, Lohse AW (2010) Immune tolerance: what is unique about the liver. J Autoimmun 34:1\u20136","journal-title":"J Autoimmun"},{"key":"8335_CR53","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.jaut.2009.08.002","volume":"34","author":"D Novick","year":"2010","unstructured":"Novick D, Elbirt D, Miller G, Dinarello CA, Rubinstein M, Sthoeger ZM (2010) High circulating levels of free interleukin-18 in patients with active SLE in the presence of elevated levels of interleukin-18 binding protein. J Autoimmun 34:121\u2013126","journal-title":"J Autoimmun"},{"key":"8335_CR54","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.jaut.2010.06.018","volume":"35","author":"C Scheinecker","year":"2010","unstructured":"Scheinecker C, Bonelli M, Smolen JS (2010) Pathogenetic aspects of systemic lupus erythematosus with an emphasis on regulatory T cells. J Autoimmun 35:269\u2013275","journal-title":"J Autoimmun"},{"key":"8335_CR55","doi-asserted-by":"crossref","unstructured":"Zandman-Goddard G, Orbach H, Agmon-Levin N et al (2011) Hyperferritinemia is associated with serologic antiphospholipid syndrome in SLE patients. Clin Rev Allergy Immunol. doi: 10.1007\/s12016-011-8264-0","DOI":"10.1007\/s12016-011-8264-0"},{"key":"8335_CR56","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.autrev.2010.10.003","volume":"10","author":"GM Sousa","year":"2011","unstructured":"Sousa GM, Oliveira RC, Pereira MM, Parana R, Sousa-Atta ML, Atta AM (2011) Autoimmunity in hepatitis C virus carriers: involvement of ferritin and prolactin. Autoimmun Rev 10:210\u2013213","journal-title":"Autoimmun Rev"},{"key":"8335_CR57","doi-asserted-by":"crossref","unstructured":"Kherbeck N, Tamby MC, Bussone G et al (2011) The role of inflammation and autoimmunity in the pathophysiology of pulmonary arterial hypertension. Clin Rev Allergy Immunol. doi: 10.1007\/s12016-011-8265-z","DOI":"10.1007\/s12016-011-8265-z"},{"key":"8335_CR58","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jaut.2011.09.004","volume":"38","author":"Y Yan","year":"2012","unstructured":"Yan Y, Wang YH, Diamond B (2012) IL-6 contributes to an immune tolerance checkpoint in post germinal center B cells. J Autoimmun 38:1\u20139","journal-title":"J Autoimmun"},{"key":"8335_CR59","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.jaut.2010.12.001","volume":"36","author":"R Aricha","year":"2011","unstructured":"Aricha R, Mizrachi K, Fuchs S, Souroujon MC (2011) Blocking of IL-6 suppresses experimental autoimmune myasthenia gravis. J Autoimmun 36:135\u2013141","journal-title":"J Autoimmun"},{"key":"8335_CR60","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.jaut.2009.08.003","volume":"34","author":"C Drucker","year":"2010","unstructured":"Drucker C, Gewiese J, Malchow S, Scheller J, Rose-John S (2010) Impact of interleukin-6 classic- and trans-signaling on liver damage and regeneration. J Autoimmun 34:29\u201337","journal-title":"J Autoimmun"},{"key":"8335_CR61","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.jaut.2010.06.020","volume":"35","author":"S Lisi","year":"2010","unstructured":"Lisi S, Sisto M, Lofrumento DD et al (2010) Pro-inflammatory role of Anti-Ro\/SSA autoantibodies through the activation of Furin-TACE-amphiregulin axis. J Autoimmun 35:160\u2013170","journal-title":"J Autoimmun"},{"key":"8335_CR62","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/j.autrev.2010.07.003","volume":"9","author":"NY Hemdan","year":"2010","unstructured":"Hemdan NY, Birkenmeier G, Wichmann G et al (2010) Interleukin-17-producing T helper cells in autoimmunity. Autoimmun Rev 9:785\u2013792","journal-title":"Autoimmun Rev"},{"key":"8335_CR63","doi-asserted-by":"crossref","unstructured":"Chan AL, Rafii R, Louie S and Albertson TE (2011) Therapeutic update in idiopathic pulmonary fibrosis. Clin Rev Allergy Immunol","DOI":"10.1155\/2011\/257496"},{"key":"8335_CR64","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.jaut.2011.08.002","volume":"37","author":"AT Borchers","year":"2011","unstructured":"Borchers AT, Leibushor N, Cheema GS, Naguwa SM, Gershwin ME (2011) Immune-mediated adverse effects of biologicals used in the treatment of rheumatic diseases. J Autoimmun 37:273\u2013288","journal-title":"J Autoimmun"},{"key":"8335_CR65","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1016\/j.autrev.2010.07.011","volume":"9","author":"Z Szekanecz","year":"2010","unstructured":"Szekanecz Z, Szanto S, Szabo Z et al (2010) Biologics\u2014beyond the joints. Autoimmun Rev 9:820\u2013824","journal-title":"Autoimmun Rev"},{"key":"8335_CR66","doi-asserted-by":"crossref","unstructured":"Gualtierotti R, Biggioggero M and Meroni PL (2011) Cutting-edge issues in coronary disease and the primary antiphospholipid syndrome. Clin Rev Allergy Immunol. doi: 10.1007\/s12016-011-8268-9","DOI":"10.1007\/s12016-011-8268-9"},{"key":"8335_CR67","doi-asserted-by":"crossref","first-page":"J209","DOI":"10.1016\/j.jaut.2011.11.009","volume":"38","author":"YM Torre de la","year":"2012","unstructured":"de la Torre YM, Pregnolato F, D\u2019Amelio F et al (2012) Anti-phospholipid induced murine fetal loss: novel protective effect of a peptide targeting the beta2 glycoprotein I phospholipid-binding site. Implications for human fetal loss. J Autoimmun 38:J209\u2013J215","journal-title":"J Autoimmun"},{"key":"8335_CR68","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.autrev.2010.11.002","volume":"10","author":"J Saponjski","year":"2011","unstructured":"Saponjski J, Stojanovich L, Djokovic A, Petkovic M, Mrda D (2011) Systemic vascular diseases in the antiphospholipid syndrome. What is the best diagnostic choice? Autoimmun Rev 10:235\u2013237","journal-title":"Autoimmun Rev"},{"key":"8335_CR69","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1007\/s12016-009-8179-1","volume":"39","author":"R Cervera","year":"2010","unstructured":"Cervera R, Balasch J (2010) Autoimmunity and recurrent pregnancy losses. Clin rev allergy immunol 39:148\u2013152","journal-title":"Clin rev allergy immunol"},{"key":"8335_CR70","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1007\/s12016-009-8144-z","volume":"38","author":"S Carolis De","year":"2010","unstructured":"De Carolis S, Botta A, Santucci S et al (2010) Predictors of pregnancy outcome in antiphospholipid syndrome: a review. Clin rev allergy immunol 38:116\u2013124","journal-title":"Clin rev allergy immunol"},{"key":"8335_CR71","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/s12016-009-8146-x","volume":"38","author":"M Blank","year":"2010","unstructured":"Blank M, Shoenfeld Y (2010) Antiphospholipid antibody-mediated reproductive failure in antiphospholipid syndrome. Clin rev allergy immunol 38:141\u2013147","journal-title":"Clin rev allergy immunol"},{"key":"8335_CR72","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.autrev.2010.08.005","volume":"10","author":"D Erkan","year":"2010","unstructured":"Erkan D, Espinosa G, Cervera R (2010) Catastrophic antiphospholipid syndrome: updated diagnostic algorithms. Autoimmun Rev 10:74\u201379","journal-title":"Autoimmun Rev"},{"key":"8335_CR73","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.autrev.2010.10.008","volume":"10","author":"S Pittschieler","year":"2011","unstructured":"Pittschieler S, Wiedermann FJ (2011) Catastrophic antiphospholipid syndrome associated with methicillin-resistant Staphylococcus aureus infection. Autoimmun Rev 10:238","journal-title":"Autoimmun Rev"},{"key":"8335_CR74","doi-asserted-by":"crossref","unstructured":"Ideguchi H, Ohno S, Uehara T and Ishigatsubo Y (2011) Pregnancy outcomes in Japanese patients with SLE: retrospective review of 55 pregnancies at a university hospital. Clin Rev Allergy Immunol. doi: 10.1007\/s12016-011-8269-8","DOI":"10.1007\/s12016-011-8269-8"},{"key":"8335_CR75","doi-asserted-by":"crossref","first-page":"6622","DOI":"10.4049\/jimmunol.0902765","volume":"184","author":"A Lambrianides","year":"2010","unstructured":"Lambrianides A, Carroll CJ, Pierangeli SS et al (2010) Effects of polyclonal IgG derived from patients with different clinical types of the antiphospholipid syndrome on monocyte signaling pathways. J Immunol 184:6622\u20136628","journal-title":"J Immunol"},{"key":"8335_CR76","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.4049\/jimmunol.182.3.1756","volume":"182","author":"A Graham","year":"2009","unstructured":"Graham A, Ford I, Morrison R, Barker RN, Greaves M, Erwig LP (2009) Anti-endothelial antibodies interfere in apoptotic cell clearance and promote thrombosis in patients with antiphospholipid syndrome. J Immunol 182:1756\u20131762","journal-title":"J Immunol"},{"issue":"Suppl 4","key":"8335_CR77","doi-asserted-by":"crossref","first-page":"iv8","DOI":"10.1093\/rheumatology\/kel308","volume":"45","author":"A Tincani","year":"2006","unstructured":"Tincani A, Rebaioli CB, Taglietti M, Shoenfeld Y (2006) Heart involvement in systemic lupus erythematosus, anti-phospholipid syndrome and neonatal lupus. Rheumatology 45(Suppl 4):iv8\u2013iv13","journal-title":"Rheumatology"},{"key":"8335_CR78","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/j.autrev.2010.08.001","volume":"9","author":"F Atzeni","year":"2010","unstructured":"Atzeni F, Turiel M, Hollan I et al (2010) Usefulness of cardiovascular biomarkers and cardiac imaging in systemic rheumatic diseases. Autoimmun Rev 9:845\u2013848","journal-title":"Autoimmun Rev"},{"key":"8335_CR79","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1016\/j.autrev.2010.07.016","volume":"9","author":"S Sitia","year":"2010","unstructured":"Sitia S, Tomasoni L, Atzeni F et al (2010) From endothelial dysfunction to atherosclerosis. Autoimmun Rev 9:830\u2013834","journal-title":"Autoimmun Rev"},{"key":"8335_CR80","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.autrev.2009.11.002","volume":"9","author":"M Turiel","year":"2010","unstructured":"Turiel M, Sitia S, Atzeni F et al (2010) The heart in rheumatoid arthritis. Autoimmun Rev 9:414\u2013418","journal-title":"Autoimmun Rev"},{"key":"8335_CR81","first-page":"575","volume":"23","author":"G Ruiz-Irastorza","year":"2009","unstructured":"Ruiz-Irastorza G, Khamashta MA (2009) Managing lupus patients during pregnancy. Best practice & research. Clin Rheumatol 23:575\u2013582","journal-title":"Clin Rheumatol"},{"key":"8335_CR82","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1080\/03009740601153816","volume":"36","author":"D Paran","year":"2007","unstructured":"Paran D, Fireman E, Levartovsky D et al (2007) Pulmonary dysfunction in systemic lupus erythematosus and anti-phospholipid syndrome patients. Scand J Rheumatol 36:285\u2013290","journal-title":"Scand J Rheumatol"},{"key":"8335_CR83","doi-asserted-by":"crossref","first-page":"J327","DOI":"10.1016\/j.jaut.2009.11.004","volume":"34","author":"AA Zeki","year":"2010","unstructured":"Zeki AA, Schivo M, Chan AL et al (2010) Geoepidemiology of COPD and idiopathic pulmonary fibrosis. J Autoimmun 34:J327\u2013J338","journal-title":"J Autoimmun"},{"key":"8335_CR84","doi-asserted-by":"crossref","first-page":"J314","DOI":"10.1016\/j.jaut.2009.12.001","volume":"34","author":"V Chandran","year":"2010","unstructured":"Chandran V, Raychaudhuri SP (2010) Geoepidemiology and environmental factors of psoriasis and psoriatic arthritis. J Autoimmun 34:J314\u2013J321","journal-title":"J Autoimmun"},{"key":"8335_CR85","doi-asserted-by":"crossref","first-page":"J300","DOI":"10.1016\/j.jaut.2009.12.002","volume":"34","author":"P Invernizzi","year":"2010","unstructured":"Invernizzi P (2010) Geoepidemiology of autoimmune liver diseases. J Autoimmun 34:J300\u2013J306","journal-title":"J Autoimmun"},{"key":"8335_CR86","doi-asserted-by":"crossref","first-page":"J168","DOI":"10.1016\/j.jaut.2009.11.018","volume":"34","author":"Y Shapira","year":"2010","unstructured":"Shapira Y, Agmon-Levin N, Shoenfeld Y (2010) Defining and analyzing geoepidemiology and human autoimmunity. J Autoimmun 34:J168\u2013J177","journal-title":"J Autoimmun"},{"key":"8335_CR87","doi-asserted-by":"crossref","first-page":"J163","DOI":"10.1016\/j.jaut.2009.12.005","volume":"34","author":"P Youinou","year":"2010","unstructured":"Youinou P, Pers JO, Gershwin ME, Shoenfeld Y (2010) Geo-epidemiology and autoimmunity. J Autoimmun 34:J163\u2013J167","journal-title":"J Autoimmun"},{"key":"8335_CR88","doi-asserted-by":"crossref","first-page":"J258","DOI":"10.1016\/j.jaut.2009.12.003","volume":"34","author":"Y Arnson","year":"2010","unstructured":"Arnson Y, Shoenfeld Y, Amital H (2010) Effects of tobacco smoke on immunity, inflammation and autoimmunity. J Autoimmun 34:J258\u2013J265","journal-title":"J Autoimmun"},{"key":"8335_CR89","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.autrev.2009.06.002","volume":"9","author":"C Anzilotti","year":"2010","unstructured":"Anzilotti C, Pratesi F, Tommasi C, Migliorini P (2010) Peptidylarginine deiminase 4 and citrullination in health and disease. Autoimmun Rev 9:158\u2013160","journal-title":"Autoimmun Rev"},{"key":"8335_CR90","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.autrev.2009.04.006","volume":"9","author":"P Szodoray","year":"2010","unstructured":"Szodoray P, Szabo Z, Kapitany A et al (2010) Anti-citrullinated protein\/peptide autoantibodies in association with genetic and environmental factors as indicators of disease outcome in rheumatoid arthritis. Autoimmun Rev 9:140\u2013143","journal-title":"Autoimmun Rev"}],"container-title":["Clinical Reviews in Allergy &amp; Immunology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12016-012-8335-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12016-012-8335-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12016-012-8335-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,26]],"date-time":"2023-06-26T04:50:31Z","timestamp":1687755031000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12016-012-8335-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,10,10]]},"references-count":90,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,2]]}},"alternative-id":["8335"],"URL":"https:\/\/doi.org\/10.1007\/s12016-012-8335-x","relation":{},"ISSN":["1080-0549","1559-0267"],"issn-type":[{"value":"1080-0549","type":"print"},{"value":"1559-0267","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,10,10]]}}}